The Value of T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer - A preliminary in vivo study

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Li, Chuanming ^a   Meng, Shan ^a   Yang, Xinhua ^a   Wang, Jian ^a   Hu, Jiani ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; AXILLARY LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; AXILLA; BREAST TUMOR; CANCER STAGING; LYMPH NODE; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AREA UNDER CURVE; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; ROC CURVE;

EID: 84898606298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084038     Document Type: Article

References (31)

1. Tolaney SM, Winer EP (2007) Follow-up care of patients with breast cancer. Breast 16 (Suppl 2): S45-50.
2. Le Bouedec G, Gauthier T, Gimbergues P, Dauplat J (2008) Axillary recurrence after negative sentinel lymph node biopsy in breast cancer. Presse Med 37:1685- 1687.
3. Strnad P, Rob L, Kri'zová H, Zuntová A, Chod J, et al. (2005) Sentinel lymphatic node biopsy for breast cancer in practice. Ceska Gynekol 70:291-295. (Pubitemid 41098035)
4. Beenken SW, Urist MM, Zhang Y, Desmond R, Krontiras H, et al. (2003) Axillary Lymph Node Status, But Not Tumor Size, Predicts Locoregional Recurrence and Overall Survival After Mastectomy for Breast Cancer. Ann Surg 237: 732-739. (Pubitemid 38174539)
5. McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, et al. (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213-5219.
6. Vassallo P, Edel G, Roos N, Naguib A, Peters PE (1993) In-vitro high-resolution ultrasonography of benign and malignant lymph nodes. A sonographicpathologic correlation. Invest Radiol 28: 698-705. (Pubitemid 24081767)
7. Dooms GC, Hricak H, Crooks LE, Higgins CB (1984) Magnetic resonance imaging of the lymph nodes: comparison with CT. Radiology 153:719-728. (Pubitemid 15190049)
8. Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, et al. (2008) Utility of 18Ffluoro- deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 8: 165.
9. Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, et al. (2011) Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation. Health Technol Assess 15:1-134.
10. Mortellaro VE, Marshall J, Singer L, Hochwald SN, Chang M, et al. (2009) Magnetic resonance imaging for axillary staging in patients with breast cancer. J Magn Reson Imaging 30: 309-312.
11. Murray AD, Staff RT, Redpath TW, Gilbert FJ, Ah-See AK, et al. (2002) Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. Br J Radiol 75: 220-228. (Pubitemid 34436274)
12. Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, et al. (2010) Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 37: 1077-1086.
13. Harada T, Tanigawa N, Matsuki M, Nohara T, Narabayashi I. (2007) Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur J Radiol 63: 401-407. (Pubitemid 47321038)
14. Lim SW, Kim HW, Jun HY, Park SH, Yoon KH, et al. (2011) TCL-SPIONenhanced MRI for the detection of lymph node metastasis in murine experimental model. Acad Radiol 18:504-511.
15. Harada T, Tanigawa N, Matsuki M, Nohara T, Narabayashi I (2007) Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. European Journal of Radiology 63: 401-407. (Pubitemid 47321038)
16. Korteweg MA, Zwanenburg JJ, Hoogduin JM, van den Bosch MA, van Diest PJ, et al. (2011) Dissected Sentinel Lymph Nodes of Breast Cancer Patients: Characterization with High-Spatial-Resolution 7-T MR Imaging. Radiology 261:127-135.
17. He N, Xie C, Wei W, Pan C, Wang W, et al. (2012) A new, preoperative, MRIbased scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer Eur J Radiol 81: 2602-2612.
18. Cianfrocca M, Goldstein LJ (2004) Prognostic and predictive factors in earlystage breast cancer. Oncologist 9:606-616. (Pubitemid 39546402)
19. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, et al. (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569-575.
20. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, et al. (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136-138.
21. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, et al. (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599-609. (Pubitemid 43904843)
22. Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, et al. (2008) Percent positive axillary lymph node metastasis predicts survival in patients with nonmetastatic breast cancer. Acta Oncol 47:232-238. (Pubitemid 351164892)
23. Hildebrandt MG, Bartram P, Bak M, Højlund-Carlsen M, Petersen H, et al. (2011) Low risk of recurrence in breast cancer with negative sentinel node. Dan Med Bull 58:A4255.
24. Martin RC 2nd, Chagpar A, Scoggins CR, Edwards MJ, Hagendoorn L, et al. (2005) Clinicopathologic factors associated with false-negative sentinel lymphnode biopsy in breast cancer. Ann Surg 241:1005-1012.
25. Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, et al. (2008) Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol 19:822-824. (Pubitemid 351461058)
26. Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjøsne HE, et al. (2000) Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 10:1464-1471.
27. Kwee TC, Takahara T, Luijten PR, Nievelstein RA (2010) ADC measurements of lymph nodes: inter-and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 75: 215-220.
28. Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, et al. (2010) Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 37: 1077-1086.
29. Scaranelo AM, Eiada R, Jacks LM, Kulkarni SR, Crystal P (2012) Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. Radiology 262:425-434.
30. Luciani A, Pigneur F, Ghozali F, Dao TH, Cunin P, et al. (2009) Ex vivo MRI of axillary lymph nodes in breast cancer. European Journal of Radiology 69:59-66.
31. Zuo CS, Sung YH, Simonson DC, Habecker E, Wang J, et al. (2012) Reduced T2* values in soleus muscle of patients with type 2 diabetes mellitus. PLoS One 7:e49337.